ORKA

NASD Oruka Therapeutics, Inc.
Oct 2, 2026 · 3:43 PM ET DELAYED Market Open

$83.47 ↑ +0.05 (+0.06%) Trading Up from the previous close of $83.42, $2.53 below the day’s high of $86.00

YTD change
+175.39%
vs 20-day SMA
-7.69%
vs 200-day SMA
+31.14%

Price ranges

Previous day
$82.50 $85.00
open $82.87 close $83.42
+$0.55 (+0.66%)
Today
$83.33 $86.00
open $84.81 now $83.47
-$1.34 (-1.58%)
Past week
$81.11 $86.51
from $85.49 now $83.47
-$2.02 (-2.36%)
Past month
$81.11 $98.29
from $91.63 now $83.47
-$8.16 (-8.91%)
This year
$25.23 $115.52
from $30.31 now $83.47
+$53.16 (+175.39%)

Price & Performance

+30.11 (+56.48%) / 6M

$48.53$71.64$94.75$117.86Apr 2Jul 2Oct 1

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 27.7% away from all-time highs of $115.52
  • ORKA is up 175% since the beginning of the year
  • ORKA is up 335% over the past 12 months
  • ORKA is down 9% over the past 1 month
  • 11% of all ORKA investors are betting against ORKA

ORKA reads neutral: price sits above one of the two key moving averages, the 12-month move is +334.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.55
Earnings momentum +8.2% Quarterly EPS growth
Quarterly change +8.2%

Valuation

P/E ratio N/A
Enterprise value $4.4B
Beta -1.17

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$873.6M
Debt$2.5K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $6.2B

Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $407.27 -3.38%
MRNA Moderna, Inc. $188.94 -1.89%
RVMD Revolution Medicines, Inc. $205.89 +0.31%
ROIV Roivant Sciences Ltd. $35.50 -2.93%
BNTX BioNTech SE Sponsored ADR $96.85 -1.48%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.